Five ( < @ % ) patients died after randomisation because of septicaemia ( n = @ in the dulaglutide @ mg group ) ; pneumonia ( n = @ in the dulaglutide @ mg group ) ; cardiogenic shock ; ventricular fibrillation ; and an unknown cause ( n = @ in the glargine group ) .